(Q34974052)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19344307%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

review article

1 reference

title

Treatment of neuro-Behçet's disease: an update (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19344307%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

0 references

Afshin Borhani Haghighi

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19344307%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

author name string

Afshin Borhani Haghighi

series ordinal

1

1 reference

5 August 2017

1 April 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19344307%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

25 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19344307%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19344307%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19344307%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

page(s)

565-574

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19344307%20AND%20SRC:MED&resulttype=core&format=json

Neuro-Behçet disease. A review

25 January 2020

cites work

1 reference

Clinical patterns of neurological involvement in Behçet's disease: evaluation of 200 patients. The Neuro-Behçet Study Group

21 January 2018

1 reference

Prevalence and patterns of neurological involvement in Behcet's disease: a prospective study from Iraq

21 January 2018

1 reference

Behçet's disease and the nervous system

21 January 2018

1 reference

Epileptic seizures in Behçet disease.

21 January 2018

1 reference

The prevalence and characteristics of different types of headache in patients with Behçet's disease, a case-control study.

21 January 2018

1 reference

Depression, anxiety levels and general psychological profile in Behçet's disease.

21 January 2018

1 reference

Brain tumor-like lesion in Behçet disease

21 January 2018

1 reference

Cerebral venous thrombosis in Behçet's disease: clinical study and long-term follow-up of 25 cases

21 January 2018

1 reference

Cerebral vasculitis and ischaemic stroke in Behçet's disease: report of one case and review of the literature

21 January 2018

1 reference

The pathological presentations of neuro-Behçet disease: a case report and review of the literature

21 January 2018

1 reference

Diffusion weighted magnetic resonance imaging in Neuro-Behçet's disease

21 January 2018

1 reference

Cranial MRI in Behçet's disease: 134 examinations of 98 patients.

21 January 2018

1 reference

EULAR recommendations for the management of Behçet disease

21 January 2018

1 reference

A double-blind trial of depot corticosteroids in Behçet's syndrome

21 January 2018

1 reference

A controlled trial of azathioprine in Behçet's syndrome

21 January 2018

1 reference

Azathioprine in Behcet's syndrome: effects on long-term prognosis

21 January 2018

1 reference

Low-dose weekly methotrexate for progressive neuropsychiatric manifestations in Behcet's disease.

21 January 2018

1 reference

Reversible acute methotrexate leukoencephalopathy: atypical brain MR imaging features

21 January 2018

1 reference

Bladder and kidney cancer following cyclophosphamide therapy for non-Hodgkin's lymphoma

21 January 2018

1 reference

Chlorambucil in the treatment of uveitis and meningoencephalitis of Behçet's disease

21 January 2018

1 reference

The use of interferon alpha in Behçet disease: review of the literature

21 January 2018

1 reference

Effects of interferon alpha treatment on the clinical course of refractory Behçet's disease: an open study

21 January 2018

1 reference

Differential efficacy of human recombinant interferon-alpha2a on ocular and extraocular manifestations of Behçet disease: results of an open 4-center trial

21 January 2018

1 reference

Interferon-alpha--a new therapeutic option in refractory juvenile Behçet's disease with CNS involvement.

21 January 2018

1 reference

Pathogenesis of Adamantiades-Behçet's disease

21 January 2018

1 reference

TNFα as Therapeutic Target: New Drugs, More Applications

21 January 2018

1 reference

Anti-tumour necrosis factor alpha monoclonal antibody therapy for recalcitrant cerebral vasculitis in a patient with Behçet's syndrome.

21 January 2018

1 reference

Efficacy of TNF {alpha} blockade in cyclophosphamide resistant neuro-Behçet disease

21 January 2018

1 reference

A patient with neuro-Behçet's disease is successfully treated with etanercept: further evidence for the value of TNFalpha blockade.

21 January 2018

1 reference

Successful treatment of refractory neuro-Behcet's disease with infliximab: a case report to show its efficacy by magnetic resonance imaging, transcranial magnetic stimulation and cytokine profile.

21 January 2018

1 reference

Anti-tumor necrotic factor antibody for treatment of neuro-Behçet's disease, a case report.

21 January 2018

1 reference

Adalimumab: a new modality for Behçet's disease?

21 January 2018

1 reference

Infliximab for the treatment of Neuro-Behçet's disease: a case series and review of the literature

21 January 2018

1 reference

Effect of infliximab in progressive neuro-Behçet's syndrome

21 January 2018

1 reference

Anti-TNF therapy in the management of Behcet's disease--review and basis for recommendations.

21 January 2018

1 reference

Thalidomide in the treatment of the mucocutaneous lesions of the Behçet syndrome. A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

A double-blind trial of colchicine in Behçet's syndrome

21 January 2018

1 reference

Treatment of ocular manifestations of Behçet's disease

21 January 2018

1 reference

CNS involvement occurs more frequently in patients with Behçet's disease under cyclosporin A (CSA) than under other medications--results of a retrospective analysis of 117 cases.

21 January 2018

1 reference

Manifestation of neuro-Behçet disease in cyclosporin A therapy

21 January 2018

1 reference

Central nervous system symptoms in patients with Behçet disease receiving cyclosporine therapy.

21 January 2018

1 reference

Central nervous system toxicity related to FK506 in patients with Behçet's disease

21 January 2018

1 reference

Remission induction in Behçet's disease following lymphocyte depletion by the anti-CD52 antibody CAMPATH 1-H.

21 January 2018

1 reference

Oral tolerization with peptide 336-351 linked to cholera toxin B subunit in preventing relapses of uveitis in Behcet's disease

21 January 2018

1 reference

Vasculitis of the nervous system

21 January 2018

1 reference

Behçet's syndrome: disease manifestations, management, and advances in treatment

21 January 2018

1 reference

Major arterial involvement and review of Behcet's disease

21 January 2018

1 reference

Standard and novel therapeutic approaches to Behçet's disease

21 January 2018

1 reference

Neuro-Behçet: Acute and Sequential Aspects by MRI and MRS

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERN.09.11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19344307%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

1 reference